Adenovirus-mediated gene therapy in a mouse model of glycogen storage disease type 1a
- 1 October 2002
- journal article
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 161 (1) , S56-S61
- https://doi.org/10.1007/bf02679996
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The molecular basis of type 1 glycogen storage diseases.Current Molecular Medicine, 2001
- Molecular Genetics of Type 1 Glycogen Storage DiseasesTrends in Endocrinology & Metabolism, 1999
- Molecular cloning of a pancreatic islet-specific glucose-6-phosphatase catalytic subunit-related protein.Diabetes, 1999
- From phosphatases to vanadium peroxidases: A similar architecture of the active siteProceedings of the National Academy of Sciences, 1997
- Glucose–6–phosphatase dependent substrate transport in the glycogen storage disease type–1a mouseNature Genetics, 1996
- Structure-Function Analysis of Human Glucose-6-phosphatase, the Enzyme Deficient in Glycogen Storage Disease Type 1aJournal of Biological Chemistry, 1995
- Evaluation of the Efficacy and Safety ofIn Vitro, Adenovirus-Mediated Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator cDNAHuman Gene Therapy, 1994
- Mutations in the Glucose-6-Phosphatase Gene that Cause Glycogen Storage Disease Type 1aScience, 1993
- Gene therapy: adenovirus vectorsCurrent Opinion in Genetics & Development, 1993
- Growth in adulthood after liver transplantation for glycogen storage disease type IGastroenterology, 1991